Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

News & Analysis

China biotech company and industry news and analysis...

Week in Review: Fosun's Gland Pharma Approved for $814 Million IPO in India

Siranomics Closes $105 Million Funding from China Investors; Plans IPO

Gland Pharma, Fosun's Indian Subsidiary, Approved for $814 Million IPO

Carelink Acquires Fujifilm Flu Drug to Treat COVID-19 in China

Four China COVID-19 Vaccines Safe in 60,000 Phase III Subjects

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events

ChinaBio Partnering Forum 2020

Content Availbalble Until Dec. 21, 2020